Literature DB >> 17544117

The patient with refractory ascites.

Alexander L Gerbes1.   

Abstract

Refractory ascites indicates advanced chronic liver disease and represents a therapeutic challenge. It may be triggered by spontaneous bacterial peritonitis and denotes poor prognosis. While liver transplantation is the ultimate treatment, for the relief of ascites therapeutic paracentesis with iv-administration of albumin and/or transjugular intrahepatic portosystemic shunt (TIPS) are well established. With rapid deterioration of renal function patients can develop hepatorenal syndrome. There is increasing evidence that these patients can be bridged to transplantation with vasopressin analogs (terlipressin) and albumin.

Entities:  

Mesh:

Year:  2007        PMID: 17544117     DOI: 10.1016/j.bpg.2006.12.001

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN: 1521-6918            Impact factor:   3.043


  4 in total

1.  [Medical therapy of complications in liver cirrhosis].

Authors:  F Grünhage; J Heller; B Appenrodt; V Schmitz; T Sauerbruch
Journal:  Internist (Berl)       Date:  2007-12       Impact factor: 0.743

2.  Portal vein thrombosis and outcomes for pediatric liver transplant candidates and recipients in the United States.

Authors:  Seth A Waits; Brandon M Wojcik; Shijie Cai; Amit K Mathur; Michael J Englesbe
Journal:  Liver Transpl       Date:  2011-09       Impact factor: 5.799

3.  Changes in Kidney Function After Transjugular Intrahepatic Portosystemic Shunts Versus Large-Volume Paracentesis in Cirrhosis: A Matched Cohort Analysis.

Authors:  Andrew S Allegretti; Guillermo Ortiz; Jie Cui; Julia Wenger; Ishir Bhan; Raymond T Chung; Ravi I Thadhani; Zubin Irani
Journal:  Am J Kidney Dis       Date:  2016-03-16       Impact factor: 8.860

4.  CIRRHOTIC PATIENTS WITH ACUTE KIDNEY INJURY (AKI) HAVE HIGHER MORTALITY AFTER ABDOMINAL HERNIA SURGERY.

Authors:  Liliana Ducatti; Luciana B P Haddad; Alberto Meyer; Lucas S Nacif; Rubens M Arantes; Rodrigo B Martino; Vinicius Rocha-Santos; Daniel R Waisberg; Rafael S Pinheiro; Luiz A C D Albuquerque; Wellington Andraus
Journal:  Arq Bras Cir Dig       Date:  2022-01-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.